Detected ·
Biograil
€20M—
Danish drug delivery company Biograil™ has closed a €20M financing round backed by Verve Ventures, Megatrend Invest and HTGF Opportunity to advance its oral capsule drug delivery platform toward Phase 1 clinical testing.
- Website
- www.biograil.com
- linkedin.com/company/73462820
- Amount
- €20 000 000 EUR
- Stage
- —
- Event
- Funding round
- Detected
- 2026-11-04 16:03:29 UTC
- Signal ID
- bfc13f84-8b99-4f07-967e-15cb4f354d60
As the API returns it
{
"id": "bfc13f84-8b99-4f07-967e-15cb4f354d60",
"created_at": "2026-11-04T16:03:29.458672Z",
"company_name": "Biograil",
"company_website_url": "www.biograil.com",
"company_linkedin_url": "https://www.linkedin.com/company/73462820",
"event_type": "funding",
"funding_amount": 20000000,
"funding_currency": "EUR",
"funding_stage": null,
"message": "*Danish drug delivery company Biograil™ has closed a €20M financing round backed by Verve Ventures, Megatrend Invest and HTGF Opportunity to advance its oral capsule drug delivery platform toward Phase 1 clinical testing.*"
}